| CRC-survival (%) | 1 yr | 95 % CI | 3 yrs | 95 % CI | 5 yrs | 95 % CI | p-value# |
---|---|---|---|---|---|---|---|---|
Total | Â | 88 | 87 - 89 | 75 | 73 - 76 | 69 | 68 - 71 | Â |
Age group | 50-59Â yrs | 91 | 89 - 92 | 75 | 72 - 78 | 68 | 65 - 71 | Â |
 | 60-69 yrs | 90 | 88 - 91 | 76 | 74 - 79 | 70 | 67 - 72 | 0.016 |
 | 70-79 yrs | 85 | 84 - 87 | 71 | 69 - 72 | 66 | 64 - 68 |  |
Sex | Female | 88 | 86 - 89 | 74 | 72 - 76 | 69 | 66 - 71 | 0.156 |
 | Male | 88 | 87 - 89 | 74 | 72 - 75 | 67 | 65 - 69 |  |
Private Insurance | No | 85 | 83 - 86 | 71 | 69 - 73 | 65 | 62 - 67 | <0.001 |
 | Yes | 91 | 89 - 92 | 76 | 75 - 79 | 70 | 68 - 72 |  |
Residence | Inner urban | 88 | 87 - 89 | 75 | 72 - 76 | 69 | 66 - 69 | Â |
 | Outer urban | 87 | 84 - 90 | 76 | 71 - 80 | 71 | 66 - 75 | 0.219 |
 | Rural | 86 | 83 - 89 | 74 | 69 - 76 | 68 | 64 - 71 |  |
 | Remote | 89 | 83 - 92 | 73 | 66 - 79 | 64 | 56 - 70 |  |
 | Very remote | 84 | 67 - 92 | 75 | 57 - 86 | 59 | 38 - 76 |  |
SES (quintiles) | Least advantaged | 86 | 84 - 88 | 70 | 69 - 75 | 64 | 61 - 67 | Â |
 | Mid-low | 87 | 85 - 89 | 74 | 71 - 77 | 68 | 65 - 71 |  |
 | Mid | 87 | 85 - 89 | 74 | 72 - 78 | 69 | 66 - 72 | 0.010 |
 | Mid-high | 89 | 87 - 91 | 74 | 72 - 78 | 67 | 64 - 70 |  |
 | Most advantaged | 91 | 89 - 93 | 78 | 75 - 81 | 71 | 68 - 74 |  |
ACP Stage | A | 98 | 97 - 99 | 97 | 95- 98 | 95 | 93 - 96 | Â |
 | B | 97 | 95 - 97 | 89 | 87 - 90 | 84 | 82 - 86 |  |
 | C | 91 | 89 - 92 | 72 | 69 - 74 | 62 | 59 - 64 | <0.001 |
 | D | 54 | 50 - 58 | 18 | 15 - 21 | 9 | 7 - 12 |  |
 | Unknown | 72 | 66 - 77 | 58 | 51 - 63 | 56 | 49 - 62 |  |
Grade | Low | 93 | 87 - 97 | 87 | 79 - 92 | 85 | 77 - 90 | Â |
 | Intermediate | 93 | 92 - 94 | 81 | 80 - 82 | 75 | 73 - 76 | <0.001 |
 | High | 77 | 74 - 79 | 55 | 52 - 58 | 49 | 46 - 53 |  |
 | Unknown | 66 | 61 - 71 | 47 | 41 - 52 | 43 | 37 - 48 |  |
Site | Colon | 87 | 86 - 88 | 73 | 72 - 74 | 68 | 66 - 69 | Â |
 | Rectum | 90 | 88 - 91 | 76 | 73 - 78 | 68 | 66 - 70 | 0.747 |
Co-morbidity | None | 90 | 89 - 91 | 77 | 75 - 78 | 70 | 69 - 72 | Â |
 | One (not severe) | 87 | 85 - 89 | 73 | 70 - 76 | 68 | 64 - 71 | <0.001 |
 | Multiple / severe | 75 | 71 - 78 | 58 | 54 - 62 | 52 | 48 - 56 |  |
Surgery†| No | 46 | 41 - 51 | 24 | 20 - 28 | 19 | 16 - 24 | <0.001 |
 | Yes | 92 | 91 - 93 | 79 | 77 - 80 | 73 | 71 - 74 |  |
Radiotherapy†| No | 88 | 87 - 89 | 75 | 74 - 76 | 70 | 68 - 71 | <0.001 |
 | Yes | 87 | 84 - 89 | 67 | 63 - 71 | 57 | 53 - 61 |  |
Chemotherapy†| No | 88 | 87 - 89 | 81 | 79 - 82 | 77 | 75- 79 | <0.001 |
 | Yes | 88 | 86 - 89 | 62 | 59 - 64 | 52 | 50 - 55 |  |